Exogenous surfactant therapy for pediatric patients with the acute respiratory distress syndrome

Canadian Respiratory Journal

Volumn 4, Issue 1, 1997, Pages 21-26

  Lewis, James F ^a   Dhillon, Jasvinder S ^a   Singh, Ram N ^a  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Acute respiratory distress syndrome (ARDS); Respiratory failure; Surfactant

Indexed keywords

SURFACTANT;

ADOLESCENT; ARTICLE; ASSISTED VENTILATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNE RESPONSE; INFANT; INTENSIVE CARE; LENGTH OF STAY; NEWBORN; OXYGENATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS;

EID: 0031055938     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/903459     Document Type: Article

References (5)

1. Timmons OD, Dean JM, Vernon DD. Mortality and prognostic variables in children with adult respiratory distress syndrome. J Pediatr 1991;119:896-9.
2. Pfenninger J, Gerber A, Tscjaller J, Zimmerman A. Adult respiratory distress syndrome in children. J Pediatr 1982;101:352-7.
3. Royall JA, Levin DL. Adult respiratory distress syndrome in paediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. J Pediatr 1988;112:169-80.
4. Jobe A, Ikegami M. Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 1987;136:1256-75.
5. Petty TL, Silvers GW, Paul GW, Stanford RE. Abnormalities in lung elastic properties and surfactant function in adult respiratory distress syndrome. Chest 1979;75:571-4.